NOTCH2 and posterior cortical atrophy: In this study, we focused on Notch2, which has been reported as a target molecule for the treatment of PCa88 based on previous reports associated with tumorigenesis46–48 and malignant behavior in PCa49–52, and we first identified Notch2 as a possible direct target of miR-107 in PCa.